Pfizer Inc announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in adults. In its pivotal Phase 3 study, ZAVZPRET was statistically superior to placebo on the co-primary endpoints of pain freedom and freedom from most bothersome symptom at two hours post-dose.

Indian Pharmacopoeia commission, IPC indicated adverse drug interactions associated with widely used antibiotic cephalosporins and Amikacin.

Cephalosporins are beta-lactam antimicrobials used to manage a wide range of infections from Gram-positive and Gram-negative bacteria.And Amikacin is indicated in the treatment of serious infections due to amikacin sensitive organisms.

Indian pharmaceutical firms are struggling to deliver standard medicine to its own population which came out by a recent alert from CDSCO which notified that many pharmaceutical formulations from renowned industries are failing simple dissolution tests.

Haryana Staff Selection Commission (HSSC) is constituted by Haryana Government for the recruitment of Group C and D Services. The Commission has been constituted with the purpose of recruiting capable, competent and highly skilled individuals by conducting various examinations for different posts. The Commission is committed to develop selection and recruitment procedures that confirm to the global standards in testing and promise selections by all fair means, of the most competent, capable and skilled individuals for user departments.

Under the National Health Mission and the State Budget, the following staff positions in Kutch district are hereby advertised to be filled on a temporary basis on contract basis for 11 months and to create a waiting list. Following are the details clarifying the required qualification, high monthly salary and experience for the mentioned post.

Post : Pharmacist - RBSK

ICMR-National Institute of Immunohaematology was established in the year 1957 with an aim to conduct multidisciplinary research related to Immunohaematology offer diagnostic services and provide training to medical and non medical professionals in the field of haematology, Immunology, genetics and conduct awareness programmes on haematological disorders.

Troikaa Pharma is a leading company with the remarkable ability to constantly innovate through creative Imagination. Our NODS brands Dynapar AQ and Dynapar QPS are path breaking & have revolutionised pain care. These innovative products are backed by strong global patents. Continuous focus on innovation and an unwavering commitment to quality has helped Troikaa establish itself both in domestic and international markets. The company is driven by a visionary leadership and a strong multicultural workforce representing more than 85 countries.

IIT Ropar community has undertaken an important exercise of developing the Mission, Vision and Strategic Plan for the coming years. The exercise was carried out in active consultation with Indian Institute of Management Calcutta who have got technical expertise in this area. A participative bottom up approach was followed in formulating the Mission, Vision and Strategic Plan. Inputs from the entire IIT Ropar fraternity, MHRD, Board of Governors, Alumni and Industries were considered in the process.

Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestina, diabetology, anti-infective and pain management segments. Torrent Pharma has a strong international presence spanning over 70 countries with over 1200 product registrations.

PAREXEL has supported the Bio-Tech and Pharmaceutical industries in helping the development of new drugs and treatments on a global basis. As a leading global biopharmaceutical service provider, they supply knowledge-based contract research, medical communications and consulting services across a broad range of therapeutic areas to the worldwide pharmaceutical, biotechnology and medical device industries.

Post : Regulatory Affairs Consultant

The Institute of Nuclear Medicine and Allied Sciences (INMAS) is working in the area of biomedical and clinical research with reference to radiation, neurocognitive imaging and CBRN research. The main thrust areas of INMAS are the development of radioprotectors, development of diagnostics and therapeutic approaches using noninvasive imaging techniques, neurocognitive and endocrine functional assessment of human body.

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happinessand hope.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Post : Product Manager

Established during the Swadeshi Movement of India, Biological E. Limited started during a time when the nation sought access to critical healthcare products. Founded and led by Dr. DVK Raju, Biological E. Limited commenced its operations in 1953 as a biological products company manufacturing liver extracts and anti-coagulants.  With an objective of transitioning from treating diseases to preventing them, Biological E.

GeBBS is an ISO 9001 certified healthcare outsourcing solutions firm based in Englewood Cliffs, NJ, with multiple Global Delivery Centers located in Mumbai, India. We focus on providing Business Process Outsourcing (BPO) solutions to Healthcare Providers (Medical Billing companies, Hospitals, Faculty Practices and Large Physician groups). We help our clients succeed by leveraging on our domain expertise and our innovative and cost effective approach to global outsourcing.

Marksans Pharma Limited hereby announces that it has received final approval from US Food & Drugs Administration for its Abbreviated New Drug Application (ANDA) of Famotidine Tablets USP, 10 mg and 20 mg for over-the-counter (OTC) use.

The product is bioequivalent to the reference listed drug (RLD), Pepcid AC® tablets, a registered trademark of Johnson & Johnson Consumer Inc. which has sales of over $ 200 million in the US market.

NATCO Pharma Limited announces the launch of additional strengths for the generic version of Revlimid® (lenalidomide capsules), in 2.5 mg, and 20 mg strengths, in the United States, through its marketing partner Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.

With this launch the companies made available all the strengths of lenalidomide in the US market. Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.

Researchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer that has spread to bone to immunotherapy. Shown are two bones from mice with metastatic breast cancer. Tumors are inside the yellow outline. The left side shows an untreated tumor. The right side shows a tumor treated with a p38MAPK inhibitor. The increased green color on the right indicates the tumor is more sensitive to immunotherapy.

“To our knowledge, this is the first prospective study to report comprehensive cardiac investigations and imaging in both symptomatic and asymptomatic patients after COVID-19 vaccination,” said the study’s senior author Kate Hanneman, M.D., M.P.H., associate professor in the Department of Medical Imaging and director of cardiac imaging research at the University of Toronto in Toronto, Canada.